UTI-lizer secures 7 MSEK – to commercialize its first product
The company is aiming to support rapid and accurate urinary tract infection diagnosis, and combat antibiotic resistance.
While 2020 was a tough year in many ways and the pandemic affected some of our alumni companies heavily, we’re happy to say that fewer than expected faced severe problems and are proud to share their great results.
Spring has sprung and with it comes new results from the Sting companies that we’d like to share with you. Some highlights include:
For more results and other exciting content, download our latest annual report in full.